Navigation Links
CB1400, Patented by Canopus BioPharma, Prevents Tumor Growth and Enhances the Anti-Tumor Effects of Cisplatin and Cetuximab (Erbitux).
Date:6/19/2008

LOS ANGELES, California, June 19 /PRNewswire-FirstCall/ -- Canopus BioPharma, Inc. (OTC: CBIA), has confirmed the efficacy of its oncology candidate, CB1400, as a tumor reducing agent and has also demonstrated the synergistic effect of this drug in combination with both cisplatin and cetuximab (Erbitux) in two mice lung cancer models.

Chairman of Canopus BioPharma, Dr. Patrick Prendergast, stated, "We at Canopus are encouraged with the discovery of this new use for CB1400 to increase efficacy and reduce toxicity issues associated with conventional chemotherapeutic agents."

CB1400, a former schistosomal drug, is currently in phase II clinical development as an anti-mucositis preventative agent in patients receiving radio- and/or chemotherapy treatment. Current anti-mucositis drugs have shown tumor-protective properties. For this reason CB1400 was evaluated by Canopus to determine its effect on tumor growth.

In work carried out by the Harvard School of Dental Medicine, Boston, on behalf of Canopus BioPharma, it was confirmed that CB1400 as a single agent significantly reduces tumor growth. In an initial study, tumor growth was inhibited by 48.8% in mice treated with cisplatin, the most commonly used chemotherapy drug. CB1400 alone showed 62.3% tumor growth inhibition while the combination of both compounds further increased inhibition to 69.6%, thus confirming a synergistic effect between cisplatin and CB1400. In addition, there was no evidence of toxicity based on observations of survival and weight change in the mice and there was no evidence that CB1400 protected the tumor.

Cisplatin is a platinum-containing chemotherapeutic drug, administered by IV injection which has been used for more than 30 years to treat various forms of cancer. Enhanced efficacy with CB1400 may prevent the development of drug resistance that is common with cisplatin.

In a similar study, tumor growth was inhibited by 61% in mice treated with cetuximab
'/>"/>

SOURCE Canopus BioPharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. China Biopharma, Inc. Announces New Plan of Operation
2. Flash Technology Prevents Pain From Carpal Tunnel Syndrome
3. InSightec Resumes Clinical Trials for Non-Invasive Treatment of Brain Tumors
4. ChemoCentryx Demonstrates Recently Discovered Chemokine Receptor CXCR7 is Essential in Tumor Growth
5. First New Class of Platinum-Based Chemotherapy Drug Candidates in 30 Years Demonstrate Ability to Kill Tumors Resistant to Currently Marketed Platinum Drugs
6. New Oral MEK Inhibitor, RDEA119, Shows Favorable Anti-Tumor Properties
7. ANX-514 Reduces Hypersensitivity Reactions Without Impacting Pharmacokinetics or Antitumor Activity in Preclinical Tests
8. Celator(R) Pharmaceuticals Study Shows CPX-571 Maintains Synergistic Ratio of Irinotecan and Cisplatin to Improve Anti-tumor Activity
9. Elekta Announces Elekta Infinity - a New System for Faster and More Precise Treatment of Cancer Tumors
10. On the road to a new cancer therapy -- starving the tumor
11. Virginia Commonwealth University to Study Genomics-Based Diagnostic Test: Pathwork Diagnostics Tissue of Origin Test Designed to Aid in Determination of a Tumors Origin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... , ROCHESTER, Minn. and ... 2015 Baxter Ventures, the venture arm of ... Clinic and Velocity Pharmaceutical Development, LLC ("VPD") today announced ... a unique collaboration model initiated by Baxter Ventures to ... in the areas of immunology, hematology, and oncology. Following ...
(Date:6/1/2015)...   Epic Sciences, Inc. , a private diagnostics ... personalize and advance the treatment and management of cancer, ... under its existing credit facility with Silicon Valley ... capacity of the facility from $5 million to $15 ... to April 1, 2019.  The availability of additional capital ...
(Date:6/1/2015)... 2015 Shire plc (LSE: SHP, ... participating in the Jefferies 2015 Global Healthcare Conference in ... June 2, 2015. Jeff Poulton , Chief Financial ... at 10:00 a.m. ET (3:00 p.m. BST). ... Presentations and Webcasts section of Shire,s Investor website at ...
(Date:6/1/2015)... May 29, 2015 Research and ... of the "2015 Assessments of Leading ... and Recent Market Entrants" report to ... report from VPGMarketResearch.com provides insightful profiles of ... entrants. The report presents strategic ...
Breaking Biology Technology:Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation 2Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation 3Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation 4Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation 5Epic Sciences Expands Silicon Valley Bank Credit Facility 2Epic Sciences Expands Silicon Valley Bank Credit Facility 3Assessments of Leading Microbiology Market Players 2015 - Profiles of Major Suppliers and Recent Market Entrants 2
... Mails Letter to Shareholders, MONTVALE, N.J., Dec. ... announced that Glass Lewis & Co., one of ... Datascope,shareholders re-elect the Board,s nominees -- James J. ... Annual Meeting of Shareholders on,Thursday, December 20, 2007. ...
... team that includes University of Calgary scientists has shown ... including in Albertas oil sands are naturally ... discovery published in the prestigious science journal Nature ... by leading to more energy-efficient, environmentally friendly ways to ...
... of Standards and Technology (NIST) have made the first ... thin polymer films used in the manufacture of advanced ... of nanometers, but it can be enough to affect ... detailed in a new paper,* offer a new insight ...
Cached Biology Technology:Glass Lewis Recommends Datascope Shareholders Vote for Re-Election of the Board's Directors 2Glass Lewis Recommends Datascope Shareholders Vote for Re-Election of the Board's Directors 3Glass Lewis Recommends Datascope Shareholders Vote for Re-Election of the Board's Directors 4Glass Lewis Recommends Datascope Shareholders Vote for Re-Election of the Board's Directors 5Glass Lewis Recommends Datascope Shareholders Vote for Re-Election of the Board's Directors 6Glass Lewis Recommends Datascope Shareholders Vote for Re-Election of the Board's Directors 7Making gas out of crude oil 2Making gas out of crude oil 3New paper reveals nanoscale details of photolithography process 2
(Date:5/22/2015)... , May 22, 2015 ... Market by Solution (2D, 3D, Thermal, Emotion, Forensic), by Software ... User (Government and Utilities, Consumer and Home) - Global ... to grow from $2.77 Billion in 2015 to $6.19 ... Browse 79 market data Tables and   ...
(Date:5/21/2015)... -- The Sync Project™ , a global collaboration ... announced a collaborative partnership with Berklee,s Institute for ... collaboration on original research, joint course development and an ... The Sync Project and BerkleeICE are exploring the launch ... 2015-2016 academic year.  The course will ...
(Date:5/20/2015)... , May 20, 2015 NXT-ID, Inc. (NASDAQ: ... its wholly owned subsidiary, 3D-ID LLC, a company engaged ... Battelle for the biometrics technology portion of the recently ... from the Department of the Army. 3D-ID ... developed for government, law enforcement and security agencies. ...
Breaking Biology News(10 mins):Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3
... of papaya were certain trees from the Andes, the so-called ... of the papaya family instead revealed that the closest relatives ... with stinging hairs occurring from Mexico to Guatemala and El ... cloud forests in the Sierra de Juarez in Oaxaca, southern ...
... OAK BROOK, Ill. Data from computed tomography (CT) scans ... copies of fossilized bones, according to new research published online ... stored in plaster casts, or jackets, to protect them from ... of the plaster and all the sediment surrounding it, which ...
... Are monkeys, like humans, able to ascertain where objects are ... says Lau Andersen of the Aarhus University in Denmark, lead ... Research Center of Emory University, published in Springer,s journal ... to localize stimuli they do not perceive. Humans ...
Cached Biology News:Researchers use CT and 3-D printers to recreate dinosaur fossils 2Monkeys can point to objects they do not report seeing 2
Permeabilization Solution, 5X...
PCR purification kit, 100 preps...
Oxidative Stress-Inducible Protein Tyrosine Phosphatase...
Raised to 5-HIAA coupled to BSA with paraformaldehyde....
Biology Products: